For years, physicians and their patients diagnosed with low-risk prostate cancer believed that those patients were at high risk for progressive disease over time. And physicians and their patients diagnosed with a form of breast cancer known as ductal carcinoma in situ or DCIS had similar beliefs. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: breast, cancer, DCIS, Diagnosis, over-treatment, quality of life, risk | 2 Comments »
Just a few days ago, a paper in Cancer reported that familial risk for breast cancer in women appeared to be affected not only by a familial history of breast cancer but also by a familial history of prostate cancer among close family members. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: breast, cancer, correlation, prostate, risk | 1 Comment »
According to a new, systematic review of data from four independently conducted clinical trials, tamoxifen may be the most effective agent for the management of breast events induced by treatment with non-steroidal antiandrogens (e.g., bicalutamide) in men with prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management | Tagged: antiandrogen, breast, gynecomastia, pain, tamoxifen | 7 Comments »
An article in today’s New York Times (“‘Cancer’ or ‘weird cells’: which sounds deadlier?“) focuses on the question of whether many conditions currently referred to as “cancer” really are … and whether by calling them “cancer” we prejudice doctors and patients into taking overly aggressive action. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: breast, cancer, myeloma, name, prostate, risk | 9 Comments »
As we have suggested before in these reports, the question of whether mass, population-based screening for certain cancers (including prostate cancer) is really the best strategy for prevention of risk from the disease itself is a complex one. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: breast, cancer, risk, screening | 4 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 